We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
201
Incyte
INCY
$24B
$1.58M 0.04%
23,871
-3,679
-13% -$235K
BKD icon
202
Brookdale Senior Living
BKD
$3.43B
$1.57M 0.04%
231,502
-20,033
-8% -$143K
KALV
203
DELISTED
KalVista Pharmaceuticals
KALV
$1.57M 0.04%
135,552
+12,592
+10% +$158K
TFX icon
204
Teleflex
TFX
$6.15B
$1.57M 0.04%
6,343
+2,343
+59% +$547K
SLN
205
Silence Therapeutics
SLN
$554M
$1.56M 0.04%
85,701
+8,861
+12% +$165K
IDYA icon
206
IDEAYA Biosciences
IDYA
$3.49B
$1.54M 0.04%
48,604
-11,446
-19% -$434K
INTR icon
207
Inter&Co
INTR
$2.53B
$1.53M 0.04%
+229,524
New +$1.59M
BAP icon
208
Credicorp
BAP
$31.2B
$1.5M 0.04%
+8,311
New +$1.42M
POLEU
209
Andretti Acquisition Corp II Unit
POLEU
$1.5M 0.04%
+150,000
New +$1.5M
VFC icon
210
VF Corp
VFC
$5.8B
$1.5M 0.04%
+75,000
New +$1.26M
NKTR icon
211
Nektar Therapeutics
NKTR
$2.48B
$1.5M 0.04%
76,722
+7,127
+10% +$136K
EL icon
212
Estee Lauder
EL
$30.9B
$1.5M 0.04%
+15,000
New +$1.42M
BBIO icon
213
BridgeBio Pharma
BBIO
$16.2B
$1.49M 0.04%
58,596
+22,096
+61% +$580K
ADC icon
214
Agree Realty
ADC
$9.5B
$1.49M 0.04%
19,759
-15,404
-44% -$1.09M
ONC
215
BeOne Medicines Ltd
ONC
$36.7B
$1.48M 0.04%
+6,600
New +$1.19M
IONS icon
216
Ionis Pharmaceuticals
IONS
$9.06B
$1.48M 0.04%
36,957
-5,638
-13% -$262K
ORIC icon
217
Oric Pharmaceuticals
ORIC
$1.34B
$1.47M 0.04%
143,320
+28,954
+25% +$286K
EXR icon
218
Extra Space Storage
EXR
$31.6B
$1.47M 0.04%
8,147
-17,167
-68% -$2.9M
CROX icon
219
Crocs
CROX
$6.43B
$1.45M 0.04%
+10,000
New +$1.36M
CDLX icon
220
Cardlytics
CDLX
$20.7M
$1.44M 0.04%
45,000
-29,478
-40% -$1.64M
KROS icon
221
Keros Therapeutics
KROS
$211M
$1.44M 0.04%
24,752
+2,299
+10% +$114K
WEL
222
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.43M 0.04%
121,140
-3,914
-3% -$45.8K
TEVA icon
223
Teva Pharmaceuticals
TEVA
$40.6B
$1.43M 0.04%
79,132
+28,236
+55% +$494K
HALO icon
224
Halozyme
HALO
$10.2B
$1.41M 0.03%
24,683
-9,000
-27% -$516K
KIDS icon
225
OrthoPediatrics
KIDS
$596M
$1.41M 0.03%
52,022
+3,925
+8% +$119K
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.